Peritonitis and Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01977716|
Recruitment Status : Unknown
Verified October 2013 by Coordinación de Investigación en Salud, Mexico.
Recruitment status was: Not yet recruiting
First Posted : November 7, 2013
Last Update Posted : November 25, 2013
The primary objective is to analyze peritonitis rate and peritonitis bacteriology as risk factors for loss of residual renal function, technique failure and mortality in chronic kidney disease patients.
Secondary objectives are: To know the current rate of peritonitis in peritoneal dialysis population and to understand the bacteriological profile of peritonitis.
To know the rate and risk factors other than peritonitis involved in the loss of residual renal function.
To analyze the utility of alternative diagnostic tests, such as reagent strips, for early detection of peritonitis when traditional tests are not available.
To analyze the simultaneous measurement of serum creatinine and cystatin-C as alternative measurements of peritoneal clearance and residual renal function.
|Condition or disease|
|Loss of Residual Renal Function Technique Failure in Peritoneal Dialysis|
|Study Type :||Observational|
|Estimated Enrollment :||350 participants|
|Official Title:||The Role of Peritonitis in the Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients|
|Study Start Date :||December 2013|
|Estimated Primary Completion Date :||January 2016|
|Estimated Study Completion Date :||January 2016|
Incident peritoneal dialysis patients
Patients with chronic kidney disease incident to peritoneal dialysis treatment
- Loss of residual renal function [ Time Frame: 25 months ]
- Technique (peritoneal dialysis) failure [ Time Frame: 25 months ]Shift to hemodialysis
- Death [ Time Frame: 25 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01977716
|Contact: Ramon Paniagua, MD, PhD||+52-55-56276900 ext firstname.lastname@example.org|
|Unidad de Investigación Médica en Enfermedades Nefrológicas, Instituto Mexicano del Seguro Social||Not yet recruiting|
|Mexico City, DF, Mexico, 06722|
|Principal Investigator: Ramon Paniagua, MD, PhD|
|Sub-Investigator: Catarina Munguia-Miranda, MD|
|Sub-Investigator: Maria de Jesus Ventura-Garcia, MSc|